Literature DB >> 10430532

Characterization of cellular density and determination of neointimal extracellular matrix constituents in human lower extremity vein graft stenoses.

A T Gentile1, J L Mills, A Westerband, M A Gooden, S S Berman, C A Boswell, S K Williams.   

Abstract

UNLABELLED: Arterial restenosis has been attributed to a hyperproliferative smooth muscle cell response. Paradoxically, studies of human coronary atherectomy and vein graft stenotic lesions have demonstrated a relatively low nuclear proliferative rate with the majority of the neointimal mass consisting of extracellular matrix. The purpose of the present study was to characterize the cellular density and determine the relative composition of the extracellular matrix protein constituents in stenotic, human lower extremity vein-bypass graft lesions.
METHODS: Duplex surveillance of 148 consecutive infrainguinal bypass grafts identified 17 patients with 22 preocclusive autogenous vein graft stenoses (mean graft age 7 months). Morphological analyses of these stenotic lesions were compared with excised samples of 20 greater saphenous vein segments taken at the time of graft implantation from matched control patients. Intimal and medial areas were compared and cell density was determined with fluorescent nuclear (Bisbenzimide) staining. Differential light microscopy with pentachrome staining was performed to determine the relative percent composition of intimal matrix constituents by stereological morphometric (point-count) techniques.
RESULTS: The intimal areas for control and stenotic vein segments were 1.64 x 10(6) microm2 and 3.85 x 10(6) microm2, P < 0.0001, whereas the intimal nuclear densities (cells/unit volume) were 1.42 x 10(3) and 1.70 x 10(3) cells/microm2, P = 0.03. respectively. The corresponding medial area and medial nuclear densities were 5.01 x 10(6) microm2, 3.31 x 10(6) microm2; P = 0.08, and 2.27 x 10(3), 3.29 x 10(3); P = 0.001, for control and stenotic specimens, respectively. The intima:media area ratios were much greater, whereas the intimal and medial cell densities were only slightly greater in the stenotic compared with control veins. The relative composition of intimal extracellular matrix proteins of stenotic vein graft segments consisted of 21% cellular (fibrous) material, 33% collagen, and 46% glycosaminoglycan ground substance.
CONCLUSION: The intimal lesions responsible for lower extremity vein graft stenosis are more hypertrophic than hyperplastic. Therapies aimed at preventing arterial and vein graft restenosis may thus need to inhibit matrix biosynthetic processes in addition to cellular proliferation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10430532     DOI: 10.1016/s0967-2109(98)00093-3

Source DB:  PubMed          Journal:  Cardiovasc Surg        ISSN: 0967-2109


  5 in total

Review 1.  A role for proteoglycans in vascular disease.

Authors:  Thomas N Wight
Journal:  Matrix Biol       Date:  2018-02-27       Impact factor: 11.583

2.  Established neointimal hyperplasia in vein grafts expands via TGF-beta-mediated progressive fibrosis.

Authors:  Zhihua Jiang; Ming Tao; Kerri A Omalley; Danlu Wang; C Keith Ozaki; Scott A Berceli
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-07-17       Impact factor: 4.733

3.  Proliferative capacity of vein graft smooth muscle cells and fibroblasts in vitro correlates with graft stenosis.

Authors:  Richard D Kenagy; Nozomi Fukai; Seung-Kee Min; Florencia Jalikis; Ted R Kohler; Alexander W Clowes
Journal:  J Vasc Surg       Date:  2009-05       Impact factor: 4.268

4.  Cross-talk between angiotensin II and IGF-1-induced connexin 43 expression in human saphenous vein smooth muscle cells.

Authors:  Guanghong Jia; Anshu Aggarwal; Amanuel Yohannes; Deepak M Gangahar; Devendra K Agrawal
Journal:  J Cell Mol Med       Date:  2011-08       Impact factor: 5.310

5.  Versican is differentially regulated in the adventitial and medial layers of human vein grafts.

Authors:  Richard D Kenagy; Shinsuke Kikuchi; Steve P Evanko; Matthijs S Ruiter; Marco Piola; Alban Longchamp; Maurizio Pesce; Monica Soncini; Sébastien Deglise; Gianfranco B Fiore; Jacques-Antoine Haefliger; Tannin A Schmidt; Mark W Majesky; Michael Sobel; Thomas N Wight
Journal:  PLoS One       Date:  2018-09-28       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.